Press release
July 29, 2026
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
Veraxa Biotech AG - Post de-SPAC (VRXA)
First BiTAC®-related patent applications filed in H1 2026 including patents covering composition of matter and proprietary payload platform, with additional patents secured in contributing technology areas including click chemistry and conjugation technology.